CDTX logo

Cidara Therapeutics, Inc. (CDTX)

Profile

Full Name

Cidara Therapeutics, Inc.

Ticker

NASDAQ: CDTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 15, 2015

Indexes

Not included

Website

https://www.cidara.com

Employees

38

Key Details

Price

$107.40(-1.50%)

Market Cap

$2.72B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.27M(-94.52% YoY)

Annual EPS

-$26.46(-404.45% YoY)

PE Ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $107.40
    CDTX price is $107.40

    30-Day Relative Volume

    0.76
    CDTX 30-day relative volume is 0.76

    Price Performance

    Price 1-Day Change

    -1.5%
    CDTX price is down -1.5% today

    Price YTD Change

    +299.55%
    CDTX price is up +299.55% since January 1st

    Price 1-Year Change

    +726.15%
    CDTX price is up +726.15% year-on-year

    Price 3-Year Change

    +773.17%
    CDTX price is up +773.17% over the past 3 years

    Price Range

    Price All-Time High

    $382.60
    CDTX price is currently -71.93% below its historical high of $382.60

    Price 3-Year Low

    $9.20
    CDTX price is currently +1067.39% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $2.72B
    CDTX market cap is $2.72 billion

    Market Cap 3-Year Change

    +6083.35%
    CDTX market cap is up +6083.35% over the past 3 years

    Market Cap All-Time High

    $2.95B
    CDTX market cap is currently -7.53% below its historical high of $2.95 billion

    Market Cap Sector Percentile

    82.7%
    CDTX market cap is higher than 82.7% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +259.86%
    CDTX shares outstanding is up +259.86% year-on-year

    Shares Outstanding 3-Year Change

    +612.49%
    CDTX shares outstanding is up +612.49% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.02
    CDTX beta is 1.02

    200-day SMA

    $44.86
    CDTX price is currently +139.39% above its 200-day simple moving average

    50-day SMA

    $84.81
    CDTX price is currently +26.64% above its 50-day simple moving average

    14-Day RSI

    62.59
    CDTX 14-day relative strength index is 62.59

    Volume

    0.76
    CDTX 30-day relative volume is 0.76

    ATR

    $6.77
    CDTX average true range is $6.77

    10-day Historical Volatility

    61.62%
    CDTX 10-day historical volatility is 61.62%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.27M
    CDTX annual revenue is $1.27 million

    Revenue Analysts Estimate

    -
    CDTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    -94.52%
    CDTX annual revenue is down -94.52% year-on-year

    Revenue Sector Percentile

    37.79%
    CDTX annual revenue is higher than 37.79% of companies in Healthcare sector

    EPS

    EPS

    -$26.46
    CDTX annual earnings per share is -$26.46

    EPS Analysts Estimate

    -$5.99
    CDTX annual earnings per share is currently -342.12% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -404.45%
    CDTX annual earnings per share is down -404.45% year-on-year

    EPS Sector Percentile

    7.13%
    CDTX annual earnings per share is higher than 7.13% of companies in Healthcare sector

    Profit

    Gross Profit

    $1.04M
    CDTX annual gross profit is $1.04 million

    Gross Margin

    81.73%
    CDTX annual gross profit margin is 81.73%

    Operating Profit

    -$176.10M
    CDTX annual operating income is -$176.10 million

    Operating Margin

    -7154.43%
    CDTX annual operating profit margin is -7154.43%

    Net Income

    -$170.29M
    CDTX annual net profit is -$170.29 million

    Net Margin

    -13.36K%
    CDTX annual net profit margin is -13.36 thousand%

    Expenses

    Total Expenses

    $177.38M
    CDTX annual total expenses is $177.38 million

    Operating Expenses

    $177.38M
    CDTX annual total operating expenses is $177.38 million

    Cost Of Goods Sold

    $233.00K
    CDTX annual cost of goods sold is $233.00 thousand

    Selling, General & Administrative Expenses

    $20.61M
    CDTX annual SG&A is $20.61 million

    Depreciation & Amortization

    $233.00K
    CDTX annual D&A is $233.00 thousand

    Interest Expense

    $0.00
    CDTX annual interest expense is $0.00

    Income Tax

    $0.00
    CDTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$176.10M
    CDTX annual earnings before interest & taxes is -$176.10 million

    EBITDA

    -$175.87M
    CDTX annual EBITDA is -$175.87 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $215.58M
    CDTX annual total assets is $215.58 million

    Non Current Assets

    $4.06M
    CDTX annual long term assets is $4.06 million

    Current Assets

    $210.74M
    CDTX annual total current assets is $210.74 million

    Cash and Cash Equivalents

    $189.82M
    CDTX annual cash & cash equivalents is $189.82 million

    Accounts Receivable

    $1.69M
    CDTX annual accounts receivable is $1.69 million

    Inventory

    $0.00
    CDTX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $52.27M
    CDTX annual total liabilities is $52.27 million

    Long Term Liabilities

    $1.93M
    CDTX annual total long term liabilities is $1.93 million

    Current Liabilities

    $49.55M
    CDTX annual current liabilities is $49.55 million

    Accounts Payable

    $3.61M
    CDTX annual accounts payable is $3.61 million

    Debt

    Total Debt

    $3.58M
    CDTX annual total debt is $3.58 million

    Total Debt 1-Year Change

    -26.68%
    CDTX annual total debt is down -26.68% year-on-year

    Long Term Debt

    $1.93M
    CDTX annual long term debt is $1.93 million

    Short Term Debt

    $1.64M
    CDTX annual short term debt is $1.64 million

    Equity & Capital

    Shareholders Equity

    $163.31M
    CDTX annual stockholders equity is $163.31 million

    Book Value

    $163.31M
    CDTX annual book value is $163.31 million

    Retained Earnings

    -$611.26M
    CDTX annual retained earnings is -$611.26 million

    Working Capital

    $161.18M
    CDTX annual working capital is $161.18 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$176.53M
    CDTX annual cash from operations is -$176.53 million

    Cash From Operations 1-Year Change

    -686.97%
    CDTX annual cash from operations is down -686.97% year-on-year

    Cash From Investing

    -$129.00K
    CDTX annual cash from investing is -$129.00 thousand

    Cash From Investing 1-Year Change

    +74.46%
    CDTX annual cash from investing is up +74.46% year-on-year

    Cash From Financing

    $337.06M
    CDTX annual cash from financing is $337.06 million

    Cash From Financing 1-Year Change

    +1197.19%
    CDTX annual cash from financing is up +1197.19% year-on-year

    CAPEX

    CAPEX

    $129.00K
    CDTX annual capital expenditures is $129.00 thousand

    CAPEX 1-Year Change

    -74.46%
    CDTX annual capital expenditures is down -74.46% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$176.66M
    CDTX annual free cash flow is -$176.66 million

    Free Cash Flow 1-Year Change

    -670.21%
    CDTX annual free cash flow is down -670.21% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    81.73%
    CDTX annual gross profit margin is 81.73%

    Operating Margin

    -7154.43%
    CDTX annual operating profit margin is -7154.43%

    Net Margin

    -13.36K%
    CDTX annual net profit margin is -13.36 thousand%

    ROA & ROE

    ROA

    -119.88%
    CDTX annual return on assets is -119.88%

    ROE

    -219.59%
    CDTX annual return on equity is -219.59%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    CDTX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    CDTX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    5.43
    CDTX price to book ratio is 5.43

    PB Ratio Sector Percentile

    78.42%
    CDTX price to book ratio is higher than 78.42% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    CDTX price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    CDTX price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $2.21B
    CDTX enterprise value is $2.21 billion

    Enterprise Value Sector Percentile

    80.38%
    CDTX enterprise value is higher than 80.38% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -17.81
    CDTX EV/EBITDA is -17.81

    EV/EBITDA Sector Percentile

    8.91%
    CDTX EV/EBITDA is higher than 8.91% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    4.25
    CDTX annual current ratio is 4.25

    Quick Ratio

    4.25
    CDTX annual quick ratio is 4.25

    Leverage

    Debt To Equity

    0.02
    CDTX annual debt to equity ratio is 0.02

    Interest Coverage Ratio

    -
    CDTX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    CDTX piotroski f-score value is unknown

    Altman Z-Score

    25.50
    CDTX altman z-score is 25.50

    Analyst ratings

    Recent major analysts updates

    Oct 21, 25 HC Wainwright & Co.
    Buy
    Oct 16, 25 Morgan Stanley
    Overweight
    Oct 10, 25 JP Morgan
    Overweight
    Oct 9, 25 WBB Securities
    Strong Buy
    Oct 9, 25 HC Wainwright & Co.
    Buy
    Oct 3, 25 JMP Securities
    Market Outperform
    Sep 26, 25 HC Wainwright & Co.
    Buy
    Sep 25, 25 Guggenheim
    Buy
    Sep 24, 25 WBB Securities
    Strong Buy
    Sep 24, 25 Needham
    Buy

    Institutional Ownership

    Screeners with CDTX included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    • What is the ticker symbol for Cidara Therapeutics, Inc.?
    • Does Cidara Therapeutics, Inc. pay dividends?
    • What sector is Cidara Therapeutics, Inc. in?
    • What industry is Cidara Therapeutics, Inc. in?
    • What country is Cidara Therapeutics, Inc. based in?
    • When did Cidara Therapeutics, Inc. go public?
    • Is Cidara Therapeutics, Inc. in the S&P 500?
    • Is Cidara Therapeutics, Inc. in the NASDAQ 100?
    • Is Cidara Therapeutics, Inc. in the Dow Jones?
    • When was Cidara Therapeutics, Inc.'s last earnings report?
    • When does Cidara Therapeutics, Inc. report earnings?

    What is the ticker symbol for Cidara Therapeutics, Inc.?

    The ticker symbol for Cidara Therapeutics, Inc. is NASDAQ:CDTX

    Does Cidara Therapeutics, Inc. pay dividends?

    No, Cidara Therapeutics, Inc. does not pay dividends

    What sector is Cidara Therapeutics, Inc. in?

    Cidara Therapeutics, Inc. is in the Healthcare sector

    What industry is Cidara Therapeutics, Inc. in?

    Cidara Therapeutics, Inc. is in the Biotechnology industry

    What country is Cidara Therapeutics, Inc. based in?

    Cidara Therapeutics, Inc. is headquartered in United States

    When did Cidara Therapeutics, Inc. go public?

    Cidara Therapeutics, Inc.'s initial public offering (IPO) was on April 15, 2015

    Is Cidara Therapeutics, Inc. in the S&P 500?

    No, Cidara Therapeutics, Inc. is not included in the S&P 500 index

    Is Cidara Therapeutics, Inc. in the NASDAQ 100?

    No, Cidara Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Cidara Therapeutics, Inc. in the Dow Jones?

    No, Cidara Therapeutics, Inc. is not included in the Dow Jones index

    When was Cidara Therapeutics, Inc.'s last earnings report?

    Cidara Therapeutics, Inc.'s most recent earnings report was on August 7, 2025

    When does Cidara Therapeutics, Inc. report earnings?

    The next expected earnings date for Cidara Therapeutics, Inc. is November 6, 2025
    On this page